Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1775764A details a high-yield tetrazole synthesis using Yb(OTf)3. This method offers significant cost reduction in API manufacturing and improved supply chain reliability.
Novel Lewis acid catalyzed route ensures >99.9% purity and scalable production for global pharmaceutical supply chains seeking cost efficiency.
Patent CN114736315B details a novel one-pot synthesis for lentinan core fragments. This route eliminates toxic allyl protection, offering cost reduction in API manufacturing and reliable supply.
Patent CN112094205A reveals a safer liquid-phase synthesis for Fmoc-Ser(tBu)-OH, offering high chiral purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103497147B details a mild Yb(OTf)3 catalyzed route for 1,4-dihydropyridines. This method offers significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN103524308B reveals solid acid catalysis for high-purity halogenated phenol manufacturing with reduced waste and enhanced supply chain reliability.
Novel synthetic route for IMPD reference standard offering higher yield and safer conditions for pharmaceutical quality control supply chains globally.
Novel Lewis acid catalyst enables high yield trimethylacetylhydrazine production reducing costs and simplifying supply chain for global buyers seeking reliable pharmaceutical intermediates.
Patent CN110304989A reveals novel synthesis for OLED intermediates. Achieve high purity and cost reduction in electronic chemical manufacturing with scalable processes.
Advanced Lewis acid catalysis for SGLT2 inhibitor intermediates. Reduces waste salt and enhances selectivity for reliable pharmaceutical intermediate supply chains.
Advanced preparation of cyclohexene carboxylates for neuraminidase inhibitors. Optimized route offers cost reduction and scalable manufacturing for API intermediates.
Novel one-step secnidazole preparation improves yield to 60% and reduces solvent use for cost effective pharmaceutical manufacturing supply chains.
Patent CN102675283A reveals a novel acid-catalyzed condensation route for Bepotastine intermediates, offering superior chiral purity and yield compared to traditional base-mediated methods.
Patent CN114394913B introduces a metal-free heteropolyacid catalyzed synthesis of oxime ethers. This method offers significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN103214400B reveals safer hexaflumuron manufacturing. Eliminates phosgene risks, ensures high purity supply chain stability for global agrochemical buyers.
Patent CN1332948C details a solvent-free synthesis of bis-indolyl derivatives using SO4 2-/TiO2, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN106334578B reveals efficient ionic liquid catalyst. Reduces cost and improves supply chain for pharmaceutical intermediates manufacturing globally.
Patent CN106334578B reveals ionic liquid catalyst for quinoline derivatives ensuring high purity and scalable manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Patent CN108329249B introduces a scalable HMTA-based route for indole-3-carbaldehyde, offering superior purity and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN110938048B reveals a green Lewis acid-catalyzed route to dihydrofuran derivatives using sulfur ylides, offering safer and cost-effective manufacturing for pharmaceutical intermediates.